News
-
-
COMMUNIQUÉ DE PRESSE
Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy
Wellgistics Health terminates equity purchase agreement with Hudson Global Ventures, LLC to focus on long-term shareholder value. Strategic shift towards accretive financing and growth opportunities -
COMMUNIQUÉ DE PRESSE
Sekur Private Data Ltd. Receives Auditor Approval to Accept Crypto Currencies as Payment Form for Sekur Swiss Hosted Privacy Communications Solutions
Sekur Private Data Ltd. receives approval from auditors to accept cryptocurrency as payment for Swiss-hosted privacy communications solutions, amid rising cyber threats targeting the crypto community -
-
COMMUNIQUÉ DE PRESSE
Original-Research: Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates recommendation on Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG to BUY with €1.50 target price. Detailed analysis on 2024 results and 2025 outlook -
-
-
COMMUNIQUÉ DE PRESSE
Vision Marine Positions for Growth with Exclusive Nimbus Boats USA Distribution on Florida's West Coast
Vision Marine partners with Nimbus Boats USA to exclusively distribute premium Scandinavian-designed powerboats on Florida's West Coast, enhancing choices for boaters and expanding market reach -
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue
Jaguar Health, Inc. reports 35% revenue increase in Q2 2025 for prescription & non-prescription products, including license revenue. Mytesi prescription volume up 6.5%. Crofelemer trial yields positive results